Skip to content
Chat on WhatsApp
RC10

Incretin-Pathway Peptides

RC10

Retatrutide and cagrilintide combined at equal nominal mass, sealed as a lyophilized vial for comparative research.

  • Retatrutide and cagrilintide combined
  • Specification confirmed in batch documentation
  • Sealed vial, 10mg total

Research use only

RC10 is a two-component research formulation combining retatrutide and cagrilintide at equal nominal mass. It is cataloged in the incretin-pathway section alongside the other combination entries built from GLP-1, GIP, glucagon, and amylin analogues.

This entry is supplied for in-vitro comparison between the two components, analytical verification, and studies of blend compatibility. As a two-peptide blend, no single CAS number or molecular weight applies to the vial as a whole; that detail is set out per batch in the documentation.

The vial is sealed after freeze-drying and labeled with its total nominal mass of 10mg. Batch documentation is confirmed by inquiry.

Purity≥99% by HPLC
CAS numberSee batch documentation
Molecular weightSee batch documentation
Molecular formulaSee batch documentation
Material classTwo-component peptide blend
AppearanceWhite to off-white lyophilized powder
Available vial sizes10mg total
DocumentationBatch documentation confirmed on request

← Back to the catalog